# FDA Inspection 1276673 - Seres Therapeutics, Inc. - July 25, 2025

Source: https://www.keypedia.com/records/fda_inspections/seres-therapeutics-inc/89ffb60f-23bc-4c64-9209-a5d072925ae5
Source feed: FDA_Inspections

> FDA Inspection 1276673 for Seres Therapeutics, Inc. on July 25, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1276673
- Company Name: Seres Therapeutics, Inc.
- Inspection Date: 2025-07-25
- Classification: No Action Indicated (NAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1276673 - 2025-07-25](https://www.keypedia.com/records/fda_inspections/seres-therapeutics-inc/800a795a-d578-4b45-9d7f-6cda8a0e2945)
- [FDA Inspection 1202299 - 2022-12-09](https://www.keypedia.com/records/fda_inspections/seres-therapeutics-inc/d352daed-f1f8-4e5b-aa44-f68ec6b9d18e)

Company: https://www.keypedia.com/companies/seres-therapeutics-inc/1ea165f0-3cbb-477f-be05-755a851dd0c8

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d